Michael J Heiferman1,2, Vinit B Mahajan2,3, Prithvi Mruthyunjaya2,4. 1. Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois. 2. Department of Ophthalmology, Byers Eye Institute, Stanford University. 3. Veterans Affairs Palo Alto Healthcare System. 4. Department of Radiation Oncology, Stanford University, Palo Alto, California, USA.
Abstract
PURPOSE OF REVIEW: This article reviews the latest proteomic research on uveal melanoma. RECENT FINDINGS: Proteomic analysis of uveal melanoma cell lines and tissue specimens has improved our understanding of the pathophysiology of uveal melanoma and helped identify potential prognostic biomarkers. Circulating proteins in patient serum may aid in the surveillance of metastatic disease. The proteomes of aqueous and vitreous biopsy specimens may provide safer biomarkers for metastatic risk and candidate therapeutic targets in uveal melanoma. Proteomic analysis has the potential to benefit patient outcomes by improving diagnosis, prognostication, surveillance, and treatment of uveal melanoma. SUMMARY: These recent findings demonstrate that proteomic analysis is an important area of research to better understand the pathophysiology of uveal melanoma and improve the personalized management of our patients.
PURPOSE OF REVIEW: This article reviews the latest proteomic research on uveal melanoma. RECENT FINDINGS: Proteomic analysis of uveal melanoma cell lines and tissue specimens has improved our understanding of the pathophysiology of uveal melanoma and helped identify potential prognostic biomarkers. Circulating proteins in patient serum may aid in the surveillance of metastatic disease. The proteomes of aqueous and vitreous biopsy specimens may provide safer biomarkers for metastatic risk and candidate therapeutic targets in uveal melanoma. Proteomic analysis has the potential to benefit patient outcomes by improving diagnosis, prognostication, surveillance, and treatment of uveal melanoma. SUMMARY: These recent findings demonstrate that proteomic analysis is an important area of research to better understand the pathophysiology of uveal melanoma and improve the personalized management of our patients.
Authors: María Pardo; Angel García; Benjamin Thomas; Antonio Piñeiro; Alexandre Akoulitchev; Raymond A Dwek; Nicole Zitzmann Journal: Int J Cancer Date: 2006-09-01 Impact factor: 7.396
Authors: I W Reiniger; U C Schaller; C Haritoglou; R Hein; A K Bosserhoff; A Kampik; A J Mueller Journal: Graefes Arch Clin Exp Ophthalmol Date: 2005-05-20 Impact factor: 3.117
Authors: Gabriel Velez; Peter H Tang; Thiago Cabral; Galaxy Y Cho; Daniel A Machlab; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan Journal: Transl Vis Sci Technol Date: 2018-09-26 Impact factor: 3.283
Authors: Poonam Sarode; Martina Barbara Schaefer; Friedrich Grimminger; Werner Seeger; Rajkumar Savai Journal: Front Oncol Date: 2020-03-11 Impact factor: 6.244
Authors: Gabriel Velez; Huy V Nguyen; Teja Chemudupati; Cassie A Ludwig; Marcus Toral; Sunil Reddy; Prithvi Mruthyunjaya; Vinit B Mahajan Journal: Mol Cancer Date: 2021-02-24 Impact factor: 27.401